Craft
  • Home
  •  / CSPC Pharmaceutical Group
CSPC Pharmaceutical Group

CSPC Pharmaceutical Group

Revenue

¥27.9 B

FY, 2021

Market Capitalization

$113.5 B

2022-11-21

CSPC Pharmaceutical Group Summary

Company summary

Overview
CSPC Pharmaceutical Group (石药集团有限公司) is a pharmaceutical company engaged in drug development and production. It provides common generic drugs including antibiotics, cardio-cerebrovascular drugs, antipyretic analgesic drugs, digestive system drugs, oncology drugs. In addition, the company offers bulk drug products such as vitamin C, antibiotics, and caffeine.
Type
Public
Status
Active
HQ
Shijiazhuang, CN | view all locations
Website
https://www.cspc.com.hk/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key people

  • Cai Dongchen, Chairman and CEO

    LocationsView all

    2 locations detected

    • Shijiazhuang HQ

      China

      No.226 Huanghe Street

    • Hong Kong, Hong Kong Island

      Hong Kong

      Suite 3206, 32/F, Central Plaza, 18 Harbour Road

    CSPC Pharmaceutical Group Financials

    Summary financials

    Revenue (H1, 2022)
    ¥15.6B
    Gross profit (H1, 2022)
    ¥12.0B
    Net income (H1, 2022)
    ¥3.0B
    Cash (H1, 2022)
    ¥13.4B
    EBIT (H1, 2022)
    ¥3.6B
    Enterprise value
    $101.3B

    Footer menu